BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumashiro Y, Yao T, Aishima S, Hirahashi M, Nishiyama K, Yamada T, Takayanagi R, Tsuneyoshi M. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype. Hum Pathol. 2007;38:857-863. [PMID: 17320150 DOI: 10.1016/j.humpath.2006.10.020] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Mitsuma K, Taniguchi H, Kishi Y, Hiraoka N. A case of adenocarcinoma with enteroblastic differentiation of the ampulla of Vater: Ampullary fetal gut-like adenocarcinoma. Pathology International 2016;66:230-5. [DOI: 10.1111/pin.12402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Yoshizawa J, Ishizone S, Ikeyama M, Nakayama J. Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature. BMC Cancer. 2017;17:368. [PMID: 28545511 DOI: 10.1186/s12885-017-3357-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
3 Nuevo-Gonzalez JA, Cano-Ballesteros JC, Lopez B, Andueza-Lillo JA, Audibert L. Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case. J Gastrointest Cancer. 2012;43 Suppl 1:28-31. [PMID: 21826411 DOI: 10.1007/s12029-011-9310-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Zhao M, Sun L, Lai JZ, Shi H, Mei K, He X, Jin X, Lai J, Cao D. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1. Pathol Res Pract 2018;214:1707-12. [PMID: 30196987 DOI: 10.1016/j.prp.2018.07.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 He F, Fu Y, Sun Q, Geng P, Zheng Z, Pu X, Shi J, Fan X. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers. Hum Pathol 2021;115:37-46. [PMID: 33636206 DOI: 10.1016/j.humpath.2021.02.003] [Reference Citation Analysis]
6 Lew DH, Jung WT, Kim HJ, Min HJ, Ha CY, Kim HJ, Kim TH, Ko GH. [Clinicopathological characteristics and prognosis of alpha-fetoprotein producing gastric cancer]. Korean J Gastroenterol 2013;62:327-35. [PMID: 24365731 DOI: 10.4166/kjg.2013.62.6.327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Cardinale V, De Filippis G, Corsi A, La Penna A, Rossi M, Catalano C, Bianco P, De Santis A, Alvaro D. An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease. World J Hepatol 2013; 5(7): 398-403 [PMID: 23898374 DOI: 10.4254/wjh.v5.i7.398] [Reference Citation Analysis]
8 Xia R, Zhou Y, Wang Y, Yuan J, Ma X. Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments. Front Oncol 2021;11:633916. [PMID: 33912455 DOI: 10.3389/fonc.2021.633916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kamata S, Kishimoto T, Kobayashi S, Miyazaki M. Expression and localization of ATP binding cassette (ABC) family of drug transporters in gastric hepatoid adenocarcinomas. Histopathology 2008;52:747-54. [DOI: 10.1111/j.1365-2559.2008.03026.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Li XD, Wu CP, Ji M, Wu J, Lu B, Shi HB, Jiang JT. Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China. World J Surg Oncol. 2013;11:246. [PMID: 24083471 DOI: 10.1186/1477-7819-11-246] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
11 Kuroda N, Onishi K, Lee GH. Combined tubular adenocarcinoma and hepatoid adenocarcinoma arising in Barrett esophagus. Ann Diagn Pathol 2011;15:450-3. [PMID: 20952273 DOI: 10.1016/j.anndiagpath.2010.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zeng XY, Yin YP, Xiao H, Zhang P, He J, Liu WZ, Gao JB, Shuai XM, Wang GB, Wu XL, Tao KX. Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series. Curr Med Sci. 2018;38:1054-1061. [PMID: 30536069 DOI: 10.1007/s11596-018-1983-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
13 Gálvez-Muñoz E, Gallego-Plazas J, Gonzalez-Orozco V, Menarguez-Pina F, Ruiz-Maciá JA, Morcillo MA. Hepatoid adenocarcinoma of the stomach - a different histology for not so different gastric adenocarcinoma: a case report. Int Semin Surg Oncol 2009;6:13. [PMID: 19674468 DOI: 10.1186/1477-7800-6-13] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
14 Suzuki A, Koide N, Kitazawa M, Mochizuka A, Ota H, Miyagawa S. Gastric composite tumor of alpha fetoprotein-producing carcinoma/hepatoid adenocarcinoma and endocrine carcinoma with reference to cellular phenotypes. Patholog Res Int 2012;2012:201375. [PMID: 22482081 DOI: 10.1155/2012/201375] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
15 Huang J, Zhu R, Wu R, Li R, Yao N, Deng S. Hepatoid adenocarcinoma of the renal pelvis in a 59-year-old male with nephrolithiasis: Case report and review of the literature. Curr Probl Cancer 2019;43:471-6. [PMID: 30683324 DOI: 10.1016/j.currproblcancer.2018.12.007] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Fujikura K, Yamasaki T, Otani K, Kanzawa M, Fukumoto T, Ku Y, Hirose T, Itoh T, Zen Y. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas. Am J Surg Pathol 2016;40:689-96. [PMID: 26735860 DOI: 10.1097/PAS.0000000000000585] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
17 Ye MF, Tao F, Liu F, Sun AJ. Hepatoid adenocarcinoma of the stomach: A report of three cases. World J Gastroenterol 2013; 19(27): 4437-4442 [PMID: 23885160 DOI: 10.3748/wjg.v19.i27.4437] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
18 Chen E, Wei Y, Liu H, Tang C, Liu M, Peng K, Liu T. Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer. BioMed Research International 2019;2019:1-9. [DOI: 10.1155/2019/6710428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
19 Su JS, Chen YT, Wang RC, Wu CY, Lee SW, Lee TY. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: A literature review. World J Gastroenterol 2013; 19(3): 321-327 [PMID: 23372352 DOI: 10.3748/wjg.v19.i3.321] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 74] [Article Influence: 9.9] [Reference Citation Analysis]
20 Lin J, Cao Y, Yu L, Lin L. Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review. Medicine (Baltimore) 2018;97:e12336. [PMID: 30278510 DOI: 10.1097/MD.0000000000012336] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Akazawa Y, Saito T, Hayashi T, Yanai Y, Tsuyama S, Akaike K, Suehara Y, Takahashi F, Takamochi K, Ueyama H, Murakami T, Watanabe S, Nagahara A, Yao T. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. Hum Pathol 2018;78:79-88. [PMID: 29751042 DOI: 10.1016/j.humpath.2018.04.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
22 Chun H, Kwon SJ. Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer. 2011;11:23-30. [PMID: 22076198 DOI: 10.5230/jgc.2011.11.1.23] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
23 Li W, Li Q, Yu Y, Wang Y, Chen E, Chen L, Wang Z, Cui Y, Liu T. Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma. Cancer Manag Res 2020;12:11113-9. [PMID: 33173344 DOI: 10.2147/CMAR.S276969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Liu X, Cheng Y, Sheng W, Lu H, Xu X, Xu Y, Long Z, Zhu H, Wang Y. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol. 2010;34:1465-1471. [PMID: 20871221 DOI: 10.1097/pas.0b013e3181f0a873] [Cited by in Crossref: 50] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
25 Hirabayashi K, Yasuda M, Kajiwara H, Itoh J, Miyazawa M, Hirasawa T, Muramatsu T, Murakami M, Mikami M, Osamura RY. Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of MUC2, MUC5AC, MUC6, and CD10 expression. Acta Histochem Cytochem 2008;41:15-21. [PMID: 18493590 DOI: 10.1267/ahc.08008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
26 Zizi-sermpetzoglou A, Moustou E, Tsavari A, Koulia K, Voultsos M, Marinis A. Gastric Hepatoid Adenocarcinoma. Hellenic J Surg 2013;85:355-9. [DOI: 10.1007/s13126-013-0065-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Mokrim M, Belbaraka R, Allaoui M, Kairaouani M, Mahassini N, Tahri A, Errihani H. Hepatoid Adenocarcinoma of the Lung: A Case Report and Literature Review. J Gastrointest Cancer 2012;43 Suppl 1:S125-7. [PMID: 21894458 DOI: 10.1007/s12029-011-9318-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
28 Deng Z, Yin Z, Chen S, Peng Y, Wang F, Wang X. Metastatic splenic α-fetoprotein-producing adenocarcinoma: Report of a case. Surg Today 2011;41:854-8. [DOI: 10.1007/s00595-010-4336-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
29 Morita S, Yoshida A, Goto A, Ota S, Tsuta K, Yokozawa K, Asamura H, Nakajima J, Takai D, Mori M, Oka T, Tamaru J, Itoyama S, Furuta K, Fukayama M, Tsuda H. High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases. Am J Surg Pathol 2013;37:924-32. [PMID: 23629442 DOI: 10.1097/PAS.0b013e31827e1e83] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
30 Kwon MJ, Byeon S, Kang SY, Kim KM. Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum. Pathol Res Pract 2019;215:152525. [PMID: 31301878 DOI: 10.1016/j.prp.2019.152525] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Zhou K, Wang A, Ao S, Chen J, Ji K, He Q, Ji X, Wu X, Zhang J, Li Z, Bu Z, Ji J. The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis. BMC Cancer 2020;20:671. [PMID: 32680468 DOI: 10.1186/s12885-020-07031-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Xiao C, Wu F, Jiang H, Teng L, Song F, Wang Q, Yang H. Hepatoid adenocarcinoma of the stomach: Nine case reports and treatment outcomes. Oncol Lett. 2015;10:1605-1609. [PMID: 26622718 DOI: 10.3892/ol.2015.3430] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
33 Goto A, Hirahashi M, Osada M, Nakamura K, Yao T, Tsuneyoshi M, Takayanagi R, Oda Y. Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer. Virchows Arch. 2011;458:717-724. [PMID: 21538122 DOI: 10.1007/s00428-011-1086-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
34 Tsuruta S, Ohishi Y, Fujiwara M, Ihara E, Ogawa Y, Oki E, Nakamura M, Oda Y. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist. Hum Pathol 2019;88:27-38. [PMID: 30946937 DOI: 10.1016/j.humpath.2019.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
35 Ren A, Cai F, Shang YN, Ma ES, Huang ZG, Wang W, Luo J. Gastric hepatoid adenocarcinoma: A computed tomography report of six cases. World J Gastroenterol 2014; 20(40): 15001-15006 [PMID: 25356063 DOI: 10.3748/wjg.v20.i40.15001] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
36 Ieni A, Barresi V, Giuffrè G, Caruso RA, Lanzafame S, Villari L, Salomone E, Roz E, Cabibi D, Franco V, Certo G, Labate A, Nagar C, Magliolo E, Broggi B, Fazzari C, Italia F, Tuccari G. HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily. Oncol Lett 2013;6:1591-4. [PMID: 24260051 DOI: 10.3892/ol.2013.1611] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
37 Lu J, Jin M, Zhou X, Chen X, Shao Y, Jiang X. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes. APMIS 2021. [PMID: 34862662 DOI: 10.1111/apm.13196] [Reference Citation Analysis]
38 Inoue M, Sano T, Kuchiba A, Taniguchi H, Fukagawa T, Katai H. Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer. Br J Surg. 2010;97:1056-1061. [PMID: 20632272 DOI: 10.1002/bjs.7081] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
39 Malya FU, Bozkurt S, Hasbahceci M, Cipe G, Ahmad IC, Gucin Z, Karatepe O, Muslumanoglu M. A rare tumor in a patient with hepatic hydatic cyst: adrenal hepatoid adenocarcinoma. Case Rep Med 2014;2014:824574. [PMID: 24715921 DOI: 10.1155/2014/824574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
40 Osada M, Aishima S, Hirahashi M, Takizawa N, Takahashi S, Nakamura K, Tanaka M, Maehara Y, Takayanagi R, Oda Y. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma. Hum Pathol. 2014;45:1243-1250. [PMID: 24767858 DOI: 10.1016/j.humpath.2014.02.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
41 Satake N, Chikakiyo M, Yagi T, Suzuki Y, Hirose T. Gastric cancer with choriocarcinoma and yolk sac tumor components: Case report: Gastric germ cell tumor. Pathology International 2011;61:156-60. [DOI: 10.1111/j.1440-1827.2010.02635.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]